SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -14.08% |
| 2024 | -12.70% |
| 2023 | -31.67% |
| 2022 | -115.92% |
| 2021 | -165.15% |
| 2020 | 337.00% |
| 2019 | 0.00% |